Atrial Dysfunction in Arrhythmogenic Right Ventricular Cardiomyopathy
Tarek Zghaib1, Mimount Bourfiss2, Jeroen F van der Heijden2
1Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, MD (T.Z., H.T., H.C.).
Insights
Arrhythmogenic right ventricular cardiomyopathy (ARVC) patients show enlarged atria and reduced atrial function. Atrial size and function predict future atrial arrhythmias (AA) in ARVC.
Area of Science:
- Cardiology
- Cardiovascular Imaging
- Genetics
Background:
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited heart muscle disease primarily affecting the ventricles.
- Limited evidence exists regarding atrial involvement in ARVC.
- Investigating atrial changes in ARVC is crucial for understanding disease progression and predicting arrhythmias.
Purpose of the Study:
- To characterize atrial involvement in ARVC using functional cardiac magnetic resonance (CMR).
- To determine the relationship between atrial size/function and ventricular variables.
- To identify CMR-based predictors of atrial arrhythmias (AA) in ARVC patients.
Main Methods:
- Analysis of cine CMR images from 66 ARVC patients and 24 controls.
- Evaluation of biatrial volumes, ejection fractions, peak longitudinal strain, and strain rates using tissue tracking.
- Prospective follow-up for the occurrence of AA over a median of 6.8 years.
Main Results:
- ARVC patients exhibited significantly higher biatrial volumes compared to controls.
- Reduced right atrial (RA) conduit function, RA and left atrial (LA) reservoir function, and RA and LA pump function were observed in ARVC patients.
- Higher atrial volumes and impaired LA reservoir and RA conduit function predicted incident AA in multivariable analysis.
Conclusions:
- ARVC patients demonstrate enlarged atria with diminished function on functional CMR.
- Atrial parameters, including size and function, are significant predictors of incident AA in ARVC.
- These findings highlight the importance of atrial involvement in ARVC pathophysiology and arrhythmia risk.
Background:
Arrhythmogenic right ventricular cardiomyopathy (ARVC) is an inherited cardiomyopathy that is predominantly known to affect the ventricles. Evidence for atrial involvement remains limited. Therefore, we aimed to characterize atrial involvement in ARVC using functional cardiac magnetic resonance, define the extent of atrial size and function variation attributable to ventricular variables, and identify cardiac magnetic resonance-based predictors of atrial arrhythmias (AA) in ARVC.
Methods And Results:
We analyzed cine cardiac magnetic resonance images of 66 definite ARVC patients without a history of AA or severe heart failure and 24 healthy controls. Using tissue tracking, we evaluated phasic biatrial volumes, ejection fractions (EFs), peak longitudinal strain, and strain rates (SRs). The primary outcome was the occurrence of AA during 6.8 years [3.0-10.8 years] of follow-up. Compared with controls, ARVC patients had higher biatrial volumes, reduced right atrial (RA) conduit function (passive EF [RAEFpassive] and peak early-diastolic SR), reduced RA and left atrial (LA) reservoir function (peak systolic SR), and reduced RA and LA pump function (peak late-diastolic SR; P<0.05). Using multivariable analysis, predictors of increased risk of AA during follow-up were higher atrial volumes (RAVmin and LAVmin), decreased LA reservoir function (total LAEF and LA peak longitudinal strain), and decreased RA conduit function (passive RAEF and RA early-diastolic SR).
Conclusions:
Compared with controls, patients with ARVC were found to have enlarged atria with decreased function on functional cardiac magnetic resonance examination. RA and LA parameters predict incident AA after adjusting for clinical and ventricular characteristics which suggests atrial involvement in ARVC.
Related Concept Videos
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification


